Home Music intervention Top Stories of Oncology Nursing News: June 2022

Top Stories of Oncology Nursing News: June 2022


Each month, we come back to the most popular Oncology Nursing News® stories.

June 2022 topics include the evolving role of social media in connecting patients, nurses’ perspectives on future directions for CAR T-cell therapy development, and potential limitations surrounding new opioid prescribing guidelines offered by the CDC. Other highlights include a conversation with Ohio End of Life Options Founder and Executive Director Lisa Vigil Schattinger, MSN, RN, about her personal experience with physician-assisted dying and ongoing research to to determine if music can help reduce chemotherapy-induced nausea.

Approval of off-the-shelf CAR T-cell therapy options could provide greater accessibility and benefits to patients, experts say. In this feature, Oncology Nursing News® speaks with Brittney Baer, ​​BSN, RN, and Kelly Garvin, BSN, RN, OCN, about the evolution of CAR T-cell therapy options and whether off-the-shelf options may become available in the near future.

Although the CDC has worked hard to improve its opioid guidelines, many providers still believe more can be done. In this feature, Jack Kain, PharmD, discusses recent changes to clinical guidelines and remaining questions regarding optimal care with opioid therapy.

Lisa Vigil Schattinger, MSN, RN, talks about her experience with medical assistance in dying and what oncology nurses need to understand when supporting end-of-life patients.

Will the day come when the oncology nurse dispenses acetaminophen with 20 mg of Mozart? Listen to Jason Kiernan, PhD, RN, ACNP, a Michigan State University researcher, who is preparing to develop an encouraging pilot study that used a music listening intervention to influence chemotherapy-induced nausea.

The rise of social media platforms has helped create a community of teens and young adults with cancer. Hear from our CancerCare partners how social media can positively address a unique social need for this patient population.

To stay up to date with all the latest news and features Subscribe to our newsletter. As always, thanks for reading.